On this page
FKTN
fukutin
The FKTN gene provides instructions for producing the fukutin enzyme, which is critical for a protein modification process called glycosylation, particularly impacting muscle and brain development. The FKTN gene is responsible for encoding the fukutin enzyme, an important component of the glycosylation pathway.
FKTN is located on the long (q) arm of chromosome 9, at band 9q31.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 9 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The FKTN gene provides the genetic blueprint for an enzyme known as fukutin. This enzyme is present across various bodily tissues, with notable abundance in the heart, brain, and skeletal muscles. Within cellular structures, fukutin is primarily located in the Golgi apparatus, where it plays a crucial role in the modification of newly synthesised proteins.
What the gene does
Fukutin is integral to glycosylation, a chemical process where sugar molecules are appended to specific proteins. In particular, fukutin collaborates with other enzymes to attach ribitol phosphate molecules to the existing sugar chains on alpha-dystroglycan. This glycosylation is fundamental for the normal biological activity of alpha-dystroglycan. Alpha-dystroglycan acts as an anchor, linking the internal cellular framework, known as the cytoskeleton, to the extracellular matrix. In skeletal muscles, this anchoring role helps maintain the stability and protection of muscle fibres. In the brain, alpha-dystroglycan is important for guiding the migration of nerve cells during early developmental stages.
Video: Genetics 101
Chromosome location
The FKTN gene is situated on chromosome 9, specifically at position 9q31.2. This genomic location is home to the instructions for the fukutin enzyme, which consists of 461 amino acid building blocks.
Protein structure
The fukutin protein, encoded by the FKTN gene, is 461 amino acids long. A specific region spanning amino acids 6-27 has been identified as required and sufficient for interaction with POMGNT1, another protein involved in glycosylation.
Key variants
Variants in the FKTN gene can alter the fukutin enzyme's function, leading to impaired glycosylation of alpha-dystroglycan. These alterations can disrupt the normal development and function of muscles, the brain, and eyes. The inheritance pattern for conditions linked to FKTN variants is generally autosomal recessive.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1045-6C>G | - | Pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
c.1117G>T | p.Glu373Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
c.1167del | p.Lys389fs | Pathogenic/Likely pathogenic | ★★☆☆ | Cardiovascular phenotype |
c.1272dup | p.Lys425Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
c.164G>A | p.Trp55Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Cardiomyopathy |
c.180dup | p.Phe61fs | Pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
c.256_257del | p.Asn86fs | Pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
c.540del | p.Ser180fs | Pathogenic/Likely pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
c.594del | p.Lys198fs | Pathogenic/Likely pathogenic | ★★☆☆ | Dilated cardiomyopathy 1X |
c.650del | p.Pro217fs | Pathogenic | ★★☆☆ | Myopathy caused by variation in FKTN |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the FKTN gene are associated with several inherited conditions, primarily various forms of muscular dystrophy. These include Fukuyama congenital muscular dystrophy, which predominantly affects individuals of Japanese ancestry, and Walker-Warburg syndrome, a more severe form impacting the eyes, brain, and skeletal muscles. Additionally, FKTN variants have been linked to muscular dystrophy-dystroglycanopathy, type B4 (MDDGB4), characterised by muscle weakness and delayed motor skill development.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
Inheritance pattern
Conditions caused by pathogenic FKTN variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
The FKTN gene is included in several NHS England Genomic Medicine Service clinical panels, indicating its recognised role in various inherited conditions. These include panels for Arthrogryposis, Ataxia and cerebellar anomalies - childhood onset, Congenital muscular dystrophy (R79), Foetal anomalies (R21), and Paediatric or syndromic cardiomyopathy (R135). It is also assessed in panels for Cerebellar hypoplasia, Congenital disorders of glycosylation, Early onset or syndromic epilepsy, Hydrocephalus, Intellectual disability, Likely inborn error of metabolism (R98), Limb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies (R82), Malformations of cortical development, Structural eye disease (R36), and Undiagnosed metabolic disorders.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the FKTN gene?
The FKTN gene provides instructions for the fukutin enzyme, which is crucial for glycosylation, a process that adds sugar molecules to proteins. This modification is essential for the proper function of alpha-dystroglycan, a protein important for muscle stability and brain development.
Which conditions are associated with FKTN gene variants?
Variants in the FKTN gene are linked to several types of muscular dystrophy, including Fukuyama congenital muscular dystrophy, Walker-Warburg syndrome, and muscular dystrophy-dystroglycanopathy, type B4 (MDDGB4). These conditions typically affect the muscles, brain, and eyes.
How is the FKTN gene involved in muscle health?
The fukutin enzyme modifies alpha-dystroglycan, a protein that helps anchor muscle fibres. When FKTN gene variants impair this process, it can lead to instability and damage in muscle tissue, contributing to the symptoms of muscular dystrophies.
References
- Kanagawa M, Kobayashi K, Tajiri M. Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy. Cell reports. 2016. PMID: 26923585
- Gerin I, Ury B, Breloy I. ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan. Nature communications. 2016. PMID: 27194101
- Yis U, Uyanik G, Heck PB. Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype. Neuromuscular disorders : NMD. 2011. PMID: 20961758
- Cotarelo RP, Valero MC, Prados B. Two new patients bearing mutations in the fukutin gene confirm the relevance of this gene in Walker-Warburg syndrome. Clinical genetics. 2008. PMID: 18177472
- Saito Y, Yamamoto T, Mizuguchi M. Altered glycosylation of alpha-dystroglycan in neurons of Fukuyama congenital muscular dystrophy brains. Brain research. 2006. PMID: 16466646
- Murakami T, Hayashi YK, Noguchi S. Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Annals of neurology. 2006. PMID: 17036286
- Godfrey C, Escolar D, Brockington M. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Annals of neurology. 2006. PMID: 17044012
- Toda T, Kobayashi K, Takeda S. Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy. Congenital anomalies. 2003. PMID: 12893968
- de Bernabé DB, van Bokhoven H, van Beusekom E. A homozygous nonsense mutation in the fukutin gene causes a Walker-Warburg syndrome phenotype. Journal of medical genetics. 2003. PMID: 14627679
- Hayashi YK, Ogawa M, Tagawa K. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology. 2001. PMID: 11445638
- Kondo-Iida E, Kobayashi K, Watanabe M. Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). Human molecular genetics. 1999. PMID: 10545611